Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal of Medicinal Chemistry|February 1, 1989
Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivativesK Hayashi, K Nunami, J Kato, et al.
Biochemical Pharmacology|October 23, 1997
Interaction of the DNA topoisomerase II catalytic inhibitor meso-2,3-bis(3,5-dioxopiperazine-1-yl)butane (ICRF-193), a bisdioxopiperazine derivative, with the conserved region(s) of eukaryotic but not prokaryotic enzymeM Sato, R Ishida, T Narita, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1992
Studies on angiotensin converting enzyme inhibitors. VI. Synthesis and angiotensin converting enzyme inhibitory activities of the dicarboxylic acid derivative of imidapril and its diastereoisomersH Kubota, K Nunami, K Hayashi, et al.
Gene|March 18, 2000
Structural analysis of the gene encoding RP58, a sequence-specific transrepressor associated with heterochromatinG Meng, J Inazawa, R Ishida, et al.
Cancer Research|June 1, 1995
DNA topoisomerase II is the molecular target of bisdioxopiperazine derivatives ICRF-159 and ICRF-193 in Saccharomyces cerevisiaeR Ishida, M Hamatake, R A Wasserman, et al.
Journal of Oral Rehabilitation|June 22, 2016
Optimal contrast enhancement liquid for dynamic MRI of swallowingM Ohkubo, T Higaki, K Nishikawa, et al.
The Journal of Biological Chemistry|October 3, 1998
RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repressionK Aoki, G Meng, K Suzuki, et al.
Journal of Human Genetics|October 6, 2001
Linkage disequilibrium and haplotype analysis among four novel single-nucleotide polymorphisms in the human leukemia inhibitory factor (LIF) geneR Ishida, Y Ezura, H Iwasaki, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1995
Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humansM Nakashima, T Uematsu, K Kosuge, et al.
Anti-Cancer Drugs|July 1, 1996
Antitumor activity of 2-amino-4,4 alpha-dihydro-4 alpha, 7-dimethyl-3H-phenoxazine-3-one, a novel phenoxazine derivative produced by the reaction of 2-amino-5-methylphenol with bovine hemolysateR Ishida, S Yamanaka, H Kawai, et al.
Pageof 13